Assessment of an Adherent HEK293 Cell Transfection Process for Scalable AAV Production in the iCELLis® 500 Fixed-Bed Bioreactors

被引：0
|
作者：
Kaspar, Brian K. [1 ]
Gardell, Brian [2 ]
Chung, Keen [2 ]
Vallabhaneni, Deepika [2 ]
Legmann, Rachel [2 ]
机构：
[1] AveXis Inc, Bannockburn, IL USA
[2] Pall Life Sci, Westborough, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
478
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [31] Development and Scale-Up of a Transient AAV Production Process Using a Suspension-Adapted HEK293 Clone
    Ushijima, Andi
    Fong, Eva
    Patel, Sonal
    George, Henry
    Orlando, Joe
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 438 - 438
  • [32] iCELLisTM Fixed-Bed Technology for Adherent Cells Is an Efficient Scalable System for Viral Vector Production Applications
    Lesch, Hanna P.
    Valonen, Piia
    Heikkila, Kati
    Lipponen, Eevi
    Muller, Achim
    Rasanen, Eva
    Tuunanen, Tarja
    Malinen, Joonas
    Martikainen, Anne
    Salonen, Tuula
    Nurminen, Elisa M.
    Hassinen, Minna
    Karhinen, Minna
    Parker, Nigel
    Shaw, Robert
    Yla-Herttuala, Seppo
    [J]. MOLECULAR THERAPY, 2015, 23 : S267 - S268
  • [33] Large Scale Suspension Production of AAV Capsid Variant Libraries from Stable Recombinant HEK293 Cell Banks
    Todorov, Gueorgui
    Tai, Alex
    Long, Steven
    Lindquist, Alissa
    Ngoc Nguyen
    Gasmi, Mehdi
    Cepeda, Diana
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 195 - 195
  • [34] Cell line and plasmid influence on the effciency of HEK293 cells transient transfection for the production of VLP-based vaccines
    Fuenmayor Garces, Javier
    Gutierrez Granados, Sonia
    Godia Casablancas, Francesc
    Gracia, Laura Cervera
    [J]. NEW BIOTECHNOLOGY, 2016, 33 : S32 - S33
  • [35] Chemically Defined and High-Yield AAV Vector Production Medium for Suspension HEK293 Based Cell Lines
    Nishie, Toshikazu
    Takeichi, Kaho
    Uemura, Kumiko
    Sakamoto, Shuhei
    Miura, Toshiyuki
    Ishihara, Daishi
    Chono, Hideto
    Okamoto, Sachiko
    Enoki, Tatsuji
    Mineno, Junichi
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 446 - 446
  • [36] Scalable Recombinant Adeno-Associated Virus (rAAV) Production in HEK293 Cells with the Use of a Histidine-Rich Peptide as Transfection Reagent
    Arslan, Baran
    Perevoshchikova, Irina
    Gardin, Julie
    Bourbon, Pauline
    Arabshahi, Helai
    Cinek, Tomas
    Shroff, Shilpa
    Femenia, Javier
    Tang, Yvette
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 689 - 689
  • [37] Process Development of Lentiviral Vectors for Large Scale Production Using a HEK293 Producer Cell Line
    Audy, Alexandre
    Robert, Marc-Andre
    Chahal, Parminder
    Gilbert, Renald
    Gaillet, Bruno
    [J]. MOLECULAR THERAPY, 2016, 24 : S279 - S280
  • [38] Extensive comparison of HEK293 transfection process and Baculovirus expression system to manufacture an AAV8-based treatment for Crigler-Najjar syndrome
    Guianvarc'h, L.
    Collaud, F.
    Le Bec, C.
    Mingozzi, F.
    Mavilio, F.
    Hebben, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A25 - A25
  • [39] Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures
    Cervera, Laura
    Fuenmayor, Javier
    Gonzalez-Dominguez, Irene
    Gutierrez-Granados, Sonia
    Segura, Maria Mercedes
    Godia, Francesc
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 99 (23) : 9935 - 9949
  • [40] Targeted CRISPR/Cas9 Screen Identifies Superior HEK293 Cell Lines for AAV9 Production
    Grafton, Francis
    Feitzinger, Ryan
    Fisher, Kaylin
    Leveque-Eichhorn, Lily
    Reid, Chris
    Mandegar, Mo
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 631 - 631
12345